Lack of correlation between INR and warfarin dose: a role of pharmacogenotyping of CYP2C9*3 and VKORC1 for anticoagulation
Main Authors: | Salleh, Mohd Zaki, Teh , Lay Kek, Immaculate, M. L, Ngow, Harris Abdullah, Harun, Roslan |
---|---|
Format: | Conference or Workshop Item |
Language: | English |
Published: |
2009
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/5184/ http://irep.iium.edu.my/5184/ http://irep.iium.edu.my/5184/1/warfarin_Persomalized_Medicine_Hong_Kong.pdf |
Similar Items
-
VKORC1 Haplotypes in patients treated with warfarin
by: Beshna, E, et al.
Published: (2010) -
Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin
by: Teh, L. K., et al.
Published: (2011) -
CYP2C9 polymorphism: prevalence in healthy and warfarin-treated Malay and Chinese in Malaysia
by: Ngow, Harris Abdullah, et al.
Published: (2009) -
Role of pharmacodiagnostic of CYP2C9 variants in the optimization of warfarin therapy in Malaysia: a 6-month follow-up study
by: Ngow, Harris Abdullah, et al.
Published: (2008) -
The role of pharmacogenetic variation in metoprolol CYP2D6 genotypes polymorphism
by: Wan Sulaiman, Wan Mohd. Azizi, et al.
Published: (2011)